<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab3">
 <label>Table 15.3</label>
 <caption>
  <p>Screening for HCV infection</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Group</th>
    <th>Screening</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Injected illicit drug use</td>
    <td>Antibody</td>
   </tr>
   <tr>
    <td>Persons with conditions associated with a high prevalence of HCV infection including:</td>
    <td rowspan="4">Antibody or RNA</td>
   </tr>
   <tr>
    <td> HIV infection</td>
   </tr>
   <tr>
    <td> On hemodialysis</td>
   </tr>
   <tr>
    <td> Unexplained abnormal amionotransferases</td>
   </tr>
   <tr>
    <td>Earlier recipients of transfusions or organ transplants before July 1992 including:</td>
    <td>Antibody or RNA</td>
   </tr>
   <tr>
    <td> Children born to HCV-infected mothers</td>
    <td>Antibody after 18 months of age. RNA for younger ages</td>
   </tr>
   <tr>
    <td> Health care, emergency medical, and public safety workers after a needle stick injury or mucosal exposure to HCV-positive blood</td>
    <td>Antibody or RNA</td>
   </tr>
   <tr>
    <td> Present sexual partners of HCV-infected persons</td>
    <td>Antibody</td>
   </tr>
   <tr>
    <td> Children from a region with high prevalence of HCV infection</td>
    <td>Antibody</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>Modified from Mack et al. [
   <xref ref-type="bibr" rid="CR146">146</xref>]
  </p>
 </table-wrap-foot>
</table-wrap>
